Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: absent (23), missing (300), gone (960)

Iain Cameron Postdoctoral Research Prize 2024

Description: The Iain Cameron prize for best research publication by a postdoctoral researcher - 2024 • A prize of £50 will be awarded to the postdoctoral r
Url: /Media/Southampton-Clinical-Research/Downloads/Iain-Cameron-Postdoctoral-Research-Prize-2024.pdf

BRC - Education, Training and Career Development Fund - Application form 202309

Description: For Biomedical Research Centre (BRC) Education, Training and Career Development Fund The NIHR Biomedical Research Centre (BRC) Education, Training and
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Education-Training-and-Career-Development-Fund-Application-form-202309.docx

Governors' Nomination Committee Terms of Reference Dec 2022

Description: Governors’ Nomination Committee Terms of Reference Date Issued: Review Date: Document Type: 17 January 2023 January 2024 Committee
Url: /Media/UHS-website-2019/Docs/Council-of-Governors/Governors-Nomination-Committee-Terms-of-Reference-Dec-2022.pdf

Testing for gene variants in inherited breast, ovarian and prostate cancers - patient information

Description: Information about testing for gene variants in inherited breast, ovarian and prostate cancers.
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Testing-for-gene-variants-in-inherited-breast-ovarian-and-prostate-cancers-1980-PIL.pdf

Pembrolizumab2mg/kg

Description: Chemotherapy Protocol LUNG CANCER Pembrolizumab (2mg/kg) Regimen • NSCLC – Pembrolizumab (2mg/kg) Indication • Pembrolizumab is recommended as an option for treating locally advanced
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pembrolizumab2mgkg.pdf

Pembrolizumab_400mg (NSCLC)

Description: Chemotherapy Protocol LUNG CANCER Pembrolizumab (400mg) Regimen • Lung Cancer – Pembrolizumab (400mg) Indication The treatment of unt
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pembrolizumab-400mg.pdf

Pembrolizumab 200mg (NSCLC)

Description: Regimen Chemotherapy Protocol LUNG CANCER Pembrolizumab (200mg) • Lung Cancer – Pembrolizumab (200mg) Indication The treatment of unt
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pembrolizumab-200mg.pdf

Pembrolizumab 400mg (bladder)

Description: Chemotherapy Protocol BLADDER CANCER Pembrolizumab (400mg) Regimen • Bladder – Pembrolizumab (400mg) Indication • Pembrolizumab is indicated for locally advanced (i
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Pembrolizumab-400mg.pdf

Pembrolizumab 200mg (bladder)

Description: Chemotherapy Protocol BLADDER CANCER Pembrolizumab (200mg) Regimen • Bladder – Pembrolizumab (200mg) Indication • Pembrolizumab is indicated for locally advanced (i
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Pembrolizumab-200mg.pdf

Pembrolizumab_400mg (lymphoma)

Description: Chemotherapy Protocol LYMPHOMA Pembrolizumab (400mg) Regimen • Lymphoma – Pembrolizumab (400mg) Indication • Pembrolizumab is indicat
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Pembrolizumab-400mg.pdf

121 to 130 of 413

Previous … 11 12 13 14 15 … Next